Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
31 Jul 1989 - 31 May 1990
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1991
Report date:
1991

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
yes
Remarks:
limited details on test material
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(2-ethoxyethoxy)ethyl acetate
EC Number:
203-940-1
EC Name:
2-(2-ethoxyethoxy)ethyl acetate
Cas Number:
112-15-2
Molecular formula:
C8H16O4
IUPAC Name:
2-(2-ethoxyethoxy)ethyl acetate
Details on test material:
- Name of test material (as cited in study report): Ethanol, 2- (2-Ethoxyethoxy)-, acetate
- Analytical purity: no data
- Other: in the report it is also stated, that a combination aerosol was tested, whoever the combination is not named as the study report is sanitized.

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Housing: the animals were housed continously in groups of 2-5 animals in Hazelton H-1000 exposure chambers.
- Diet: was removed during exposure
- Water: was removed during exposure

Administration / exposure

Route of administration:
inhalation: aerosol
Vehicle:
- Vehicle(s)/solvent(s) used: air
Details on exposure:
TYPE OF INHALATION EXPOSURE: whole body

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Hazelton H-1000 exposure chamber
- Method of holding animals in test chamber: whole body exposure
- System of generating aerosols: Laskin nebulizers in each chamber were immersed in water bath at approximately 180 °F (82.2 °C) during each exposure to simulate the temperature under normal conditions of use. The output of the nebulizer went through a glass impactor to remove the larger particles before being diluted by the main air stream entering the exposure chamber.
- Temperature, humidity, pressure in air chamber: recorded every 30 min during exposure; 24.6 °C (mean), 66.5% (mean)
- Air change rate: 12
- Method of particle size determination: at least once daily with a cascade impactor.

Duration of treatment / exposure:
13 weeks
Frequency of treatment:
6 h/day, 5 days/week
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0.05, 0.15 and 0.5 mg/L
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
50, 150 and 500 mg/m³
Basis:
nominal conc.
No. of animals per sex per dose:
15 (core groups)
10 (additional ancilliary males in each group for specialized endpoints)
Control animals:
yes, concurrent no treatment
yes, sham-exposed

Examinations

Tissues and cell types examined:
Bone marrow, erythrocytes
Statistics:
ANOVA, GLM nodel, SAS, Tukey´s Studentized Range Test, SCheffe´s Test

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
not examined

Any other information on results incl. tables

Table 1. Result of assay as averaged data.

Treatment

Sex

N

PCE/NCE

% MNPCE

%MNN-CE

Negative control (sham-exposed)

F

5

0.92(0.37)

0.04(0.09)

0(0)

M

5

0.52(0.11)

0.02(0.04)

0(0)

Negative control (not-treated)

F

5

0.74 (0.23)

0(0)

0(0)

M

5

0.59(0.21)

0(0)

0(0)

0.05

F

5

0.81(0.29)

0.04(0.05)

0(0)

M

5

0.62(0.24)

0(0)

0(0)

0.15

 

F

5

1.17(0.49)

0(0)

0(0)

M

5

0.63(0.24)

0.02(0.04)

0(0)

0.5

 

F

5

0.82(0.30)

0.06(0.09)

0(0)

M

5

0.57(0.12)

0.02(0.04)

0(0)

(): SD

Applicant's summary and conclusion

Conclusions:
Interpretation of results: negative